Status
Delayed
Launch slip: 1 mo
Readiness
7%
Baseline 5Y
€573.5M
Adjusted 5Y
€558.5M
-€15.0M vs baseline
Plan
Task
Aug 25
Sept 25
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Regulatory
Market Access
Supply
Medical
Marketing
Marketing
Baseline On track In progress Delayed Gating task
Risks (7)
Medium
Lena VogtSingle-source cold-chain partner — concentration risk for Q1 launch volume.
Low
Sofia LangMLR approval cycle running tight — risk of delayed HCP campaign go-live.
High
Anja BeckerEMA Filing & Approval delayed by 1 month — cascade from EMA Filing & Approval
High
Markus HahnG-BA Early Benefit Assessment delayed by 1 month — cascade from EMA Filing & Approval
High
Lena VogtLaunch Stock Build (DE) delayed by 1 month — cascade from EMA Filing & Approval
Medium
Sofia LangHCP Campaign Activation delayed by 1 month — cascade from EMA Filing & Approval
Medium
Karl ReiterSales Force Training delayed by 1 month — cascade from EMA Filing & Approval
Files
Global Launch Playbook v3.2.pdf4.2 MB
EMA Submission Dossier — Module 1.zip38.1 MB
AMNOG Value Story DE.pptx12.4 MB
Global HCP Campaign Toolkit.zip120.6 MB
Master Messaging Framework v2.1.pdf3.4 MB
Phase III Topline Results — NX-217.pdf6.7 MB
EU5 Patient Journey Research.pdf14.2 MB
Global Brand Visual Identity.zip210.3 MB